300194 福安药业
已收盘 04-30 15:00:00
资讯
新帖
简况
福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产
证券之星 · 04-29 08:42
福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产
福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%
证券之星 · 04-27
福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%
图解福安药业年报:第四季度单季净利润同比下降310.05%
证券之星 · 04-26
图解福安药业年报:第四季度单季净利润同比下降310.05%
福安药业:子公司重庆庆余堂有生产销售精神药品
证券之星 · 04-24
福安药业:子公司重庆庆余堂有生产销售精神药品
福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权
证券之星 · 04-21
福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权
股市必读:福安药业(300194)4月17日董秘有最新回复
证券之星 · 04-20
股市必读:福安药业(300194)4月17日董秘有最新回复
福安药业(300194.SZ)子公司取得一项药品注册证书
智通财经 · 04-13
福安药业(300194.SZ)子公司取得一项药品注册证书
福安药业(300194)披露子公司收到舒林酸片药品注册证书公告,4月7日股价上涨2.88%
证券之星 · 04-07
福安药业(300194)披露子公司收到舒林酸片药品注册证书公告,4月7日股价上涨2.88%
股市必读:福安药业(300194)4月3日董秘有最新回复
证券之星 · 04-07
股市必读:福安药业(300194)4月3日董秘有最新回复
福安药业(300194)3月20日股东户数3.78万户,较上期减少1.37%
证券之星 · 03-24
福安药业(300194)3月20日股东户数3.78万户,较上期减少1.37%
福安药业:截止3月10日,公司股东户数为38362户
证券之星 · 03-11
福安药业:截止3月10日,公司股东户数为38362户
福安药业:截止2月27日,公司股东户数为38593户
证券之星 · 03-02
福安药业:截止2月27日,公司股东户数为38593户
福安药业(300194)披露子公司收到吗啉硝唑原料药上市申请批准通知书,2月26日股价下跌0.45%
证券之星 · 02-26
福安药业(300194)披露子公司收到吗啉硝唑原料药上市申请批准通知书,2月26日股价下跌0.45%
福安药业(300194.SZ)子公司收到一项化学原料药上市申请批准
智通财经 · 02-26
福安药业(300194.SZ)子公司收到一项化学原料药上市申请批准
福安药业:截止最新2月13日,公司股东户数为38352户
证券之星 · 02-25
福安药业:截止最新2月13日,公司股东户数为38352户
福安药业最新公告:子公司药品拟中选国家集采药品接续采购
证券之星 · 02-12
福安药业最新公告:子公司药品拟中选国家集采药品接续采购
福安药业:截止2月10日,公司股东户数为38647户
证券之星 · 02-12
福安药业:截止2月10日,公司股东户数为38647户
股市必读:福安药业(300194)2月4日董秘有最新回复
证券之星 · 02-05
股市必读:福安药业(300194)2月4日董秘有最新回复
福安药业:截止1月30日,公司股东户数为39053户
证券之星 · 02-03
福安药业:截止1月30日,公司股东户数为39053户
股市必读:福安药业(300194)预计2025年全年扣非后净利润盈利5200万元至7800万元
证券之星 · 02-02
股市必读:福安药业(300194)预计2025年全年扣非后净利润盈利5200万元至7800万元
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":4.13,"timestamp":1777532583000,"preClose":4.14,"halted":0,"volume":9214000,"delay":0,"changeRate":-0.0024,"floatShares":968000000,"shares":1190000000,"eps":0.0529,"marketStatus":"已收盘","change":-0.01,"latestTime":"04-30 15:00:00","open":4.13,"high":4.17,"low":4.12,"amount":38139300,"amplitude":0.0121,"askPrice":4.14,"askSize":6342,"bidPrice":4.13,"bidSize":1073,"shortable":0,"etf":0,"ttmEps":0.0529,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.14,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":4.55,"lowLimit":3.73,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1.11,"roa":"--","peRate":78.071834,"roe":"1.25%","epsLYR":0.06,"committee":-0.302798,"marketValue":4914000000,"turnoverRate":0.0095,"status":1,"floatMarketCap":3999000000},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2631553263","title":"福安药业:公司子公司生产的化学原料药主要用于化学药品制剂的生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553263?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:42","pubTimestamp":1777423349,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的原料药有没有应用在医药行业以外的领域?福安药业回复:您好,目前公司子公司生产的化学原料药主要用于化学药品制剂的生产,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900027086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630036057","title":"福安药业(300194)披露2026年一季度报告,4月27日股价上涨2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630036057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630036057?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:36","pubTimestamp":1777286177,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,福安药业报收于4.16元,较前一交易日上涨2.21%,最新总市值为49.49亿元。该股当日开盘4.07元,最高4.16元,最低4.05元,成交额达5468.5万元,换手率为1.37%。福安药业于2026年4月27日披露《2026年一季度报告》。报告显示,公司2026年第一季度实现营业收入407,493,108.61元,同比下降12.87%;归属于上市公司股东的净利润54,916,269.30元,同比下降20.47%;扣除非经常性损益后的净利润48,649,638.11元,同比下降25.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300194","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630381167","title":"图解福安药业年报:第四季度单季净利润同比下降310.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630381167","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630381167?lang=zh_cn&edition=full","pubTime":"2026-04-26 16:44","pubTimestamp":1777193050,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业2025年年报显示,当年度公司主营收入17.38亿元,同比下降27.31%;归母净利润7699.71万元,同比下降72.48%;扣非净利润5964.5万元,同比下降76.93%;其中2025年第四季度,公司单季度主营收入4.23亿元,同比上升6.75%;单季度归母净利润-8926.56万元,同比下降310.05%;单季度扣非净利润-8885.23万元,同比下降262.75%;负债率24.26%,投资收益1.38亿元,财务费用-731.28万元,毛利率36.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600010214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815251","title":"福安药业:子公司重庆庆余堂有生产销售精神药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815251?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:06","pubTimestamp":1777017973,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:公司产品有没有麻醉药品和精神药品定点生产企业资质?福安药业回复:公司子公司重庆庆余堂有生产销售精神药品,具备相关药品生产的企业资质,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400047835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","BK0239","BK0060","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629850680","title":"福安药业:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2629850680","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629850680?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:54","pubTimestamp":1776758049,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问:公司参股的优诺金公司年初有一次融资,是不是有新股东看好优诺金,公司在里面的股权比例有没有变化?福安药业回复:公司子公司重庆庆余堂目前持有苏州优诺金公司20.8%股权,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100033816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0028","BK0060","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628476795","title":"股市必读:福安药业(300194)4月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628476795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628476795?lang=zh_cn&edition=full","pubTime":"2026-04-20 04:24","pubTimestamp":1776630249,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,福安药业报收于4.18元,下跌1.65%,换手率1.51%,成交量14.63万手,成交额6117.46万元。董秘最新回复投资者: 公司的首仿产品是怎么销售的?当日关注点来自交易信息汇总:4月17日主力资金净流出622.82万元,显示主力短期减持动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0132","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627859438","title":"福安药业(300194.SZ)子公司取得一项药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627859438","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627859438?lang=zh_cn&edition=full","pubTime":"2026-04-13 15:48","pubTimestamp":1776066496,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团宁波天衡制药有限公司(简称“天衡药业”)于近日收到国家药品监督管理局签发的药品注册证书,药品名称为吗啉硝唑氯化钠注射液。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","300194","BK0060","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625437959","title":"福安药业(300194)披露子公司收到舒林酸片药品注册证书公告,4月7日股价上涨2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625437959","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625437959?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:25","pubTimestamp":1775571919,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,福安药业报收于4.28元,较前一交易日上涨2.88%,最新总市值为50.92亿元。该股当日开盘4.18元,最高4.29元,最低4.08元,成交额达1.17亿元,换手率为2.87%。福安药业(集团)股份有限公司于2026年4月7日披露公告称,公司全资子公司庆余堂收到国家药品监督管理局签发的舒林酸片药品注册证书,注册分类为化药3类,批准结论为符合药品注册要求,批准注册。舒林酸片适用于骨关节炎、类风湿性关节炎等多种炎症及疼痛适应症。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625608758","title":"股市必读:福安药业(300194)4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625608758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625608758?lang=zh_cn&edition=full","pubTime":"2026-04-07 01:10","pubTimestamp":1775495424,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,福安药业报收于4.16元,下跌3.03%,换手率2.77%,成交量26.77万手,成交额1.12亿元。董秘最新回复投资者: 请问截至2026年3月31日,公司最新股东数是多少?董秘: 截止3月31日,公司股东户数为38547户,谢谢!交易信息汇总资金流向4月3日主力资金净流出2843.02万元,占总成交额25.33%;游资资金净流入785.78万元,占总成交额7.0%;散户资金净流入2057.24万元,占总成交额18.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0028","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621068835","title":"福安药业(300194)3月20日股东户数3.78万户,较上期减少1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621068835?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:17","pubTimestamp":1774343851,"startTime":"0","endTime":"0","summary":"证券之星消息,近日福安药业披露,截至2026年3月20日公司股东户数为3.78万户,较3月10日减少527.0户,减幅为1.37%。在化学制药行业个股中,福安药业股东户数高于行业平均水平,截至3月20日,化学制药行业平均股东户数为3.41万户。从股价来看,2026年3月10日至2026年3月20日,福安药业区间跌幅为5.56%,在此期间股东户数减少527.0户,减幅为1.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400028886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0132","BK0239","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618143389","title":"福安药业:截止3月10日,公司股东户数为38362户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618143389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618143389?lang=zh_cn&edition=full","pubTime":"2026-03-11 15:57","pubTimestamp":1773215833,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问截止到2026年3月10日,贵公司股东户数是多少?谢谢啦!!!福安药业回复:截止3月10日,公司股东户数为38362户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100023813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0132","BK0028","300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616386766","title":"福安药业:截止2月27日,公司股东户数为38593户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616386766","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616386766?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:45","pubTimestamp":1772437513,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2月底的股东人数是多少?谢谢福安药业回复:截止2月27日,公司股东户数为38593户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200017153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0060","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614023395","title":"福安药业(300194)披露子公司收到吗啉硝唑原料药上市申请批准通知书,2月26日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614023395","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614023395?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:42","pubTimestamp":1772116938,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,福安药业报收于4.44元,较前一交易日下跌0.45%,最新总市值为52.82亿元。该股当日开盘4.46元,最高4.48元,最低4.43元,成交额达5040.73万元,换手率为1.17%。福安药业全资子公司福安药业集团宁波天衡制药有限公司近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书,其申报的吗啉硝唑原料药获批注册。该原料药主要用于治疗由厌氧菌引起的感染性疾病,如肺炎、盆腔炎、败血症等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","300194","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614769090","title":"福安药业(300194.SZ)子公司收到一项化学原料药上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614769090","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614769090?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:05","pubTimestamp":1772093132,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团宁波天衡制药有限公司(简称“天衡制药”)于近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书,原料药名称为吗啉硝唑。吗啉硝唑主要用于治疗由厌氧菌引起的感染性疾病(如下呼吸道感染、盆腔炎、败血症等)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ)子公司收到一项化学原料药上市申请批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0132","300194","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614764777","title":"福安药业:截止最新2月13日,公司股东户数为38352户","url":"https://stock-news.laohu8.com/highlight/detail?id=2614764777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614764777?lang=zh_cn&edition=full","pubTime":"2026-02-25 11:30","pubTimestamp":1771990226,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问:请问最新一期公司的股东人数是多少?福安药业回复:截止最新2月13日,公司股东户数为38352户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500015129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","300194","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610705945","title":"福安药业最新公告:子公司药品拟中选国家集采药品接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2610705945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610705945?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:12","pubTimestamp":1770887532,"startTime":"0","endTime":"0","summary":"福安药业公告称,根据国家组织集采药品协议期满品种接续采购办公室于2月10日发布的《国家组织集采药品协议期满品种接续采购拟中选结果表》显示,公司子公司共计28个药品品种拟中选本次接续采购。公司子公司本次拟中选的28个药品品种2024年度合计销售额为6.8亿元,占公司2024年度营业收入比例为28.43%;上述拟中选的产品2025年前三季度合计销售额为3.29亿元,占公司2025年前三季度营业收入比例为25.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200027628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300194","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610917249","title":"福安药业:截止2月10日,公司股东户数为38647户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610917249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610917249?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:45","pubTimestamp":1770882318,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,请问截止至2026年2月10日收盘公司股东人数为多少,谢谢!福安药业回复:截止2月10日,公司股东户数为38647户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200020644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609394386","title":"股市必读:福安药业(300194)2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394386","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394386?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:45","pubTimestamp":1770227118,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘,福安药业报收于4.48元,上涨1.13%,换手率1.63%,成交量15.76万手,成交额7004.7万元。董秘最新回复投资者: 公司股价一直严重滞后市场!2025年,受行业政策影响,公司业绩有下降,公司已在指定媒体发布2025年业绩预告。当日关注点来自交易信息汇总:2月4日主力资金净流入635.0万元,呈现主动买入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","300194","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608825307","title":"福安药业:截止1月30日,公司股东户数为39053户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608825307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608825307?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:24","pubTimestamp":1770107066,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月31日公司股东人数是多少?谢谢!福安药业回复:截止1月30日,公司股东户数为39053户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300027039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","300194","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608895768","title":"股市必读:福安药业(300194)预计2025年全年扣非后净利润盈利5200万元至7800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608895768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608895768?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:19","pubTimestamp":1769973550,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,福安药业报收于4.49元,下跌0.66%,换手率2.03%,成交量19.67万手,成交额8863.47万元。福安药业发布业绩预告,预计2025年全年归属净利润盈利7000万元至1亿元。福安药业预计2025年度归属于上市公司股东的净利润为7,000万元至1亿元,比上年同期下降64.26%-74.99%;扣除非经常性损益后的净利润为5,200万元至7,800万元,同比下降69.83%-79.88%。剔除商誉减值影响后,净利润预计为2.2亿元至2.5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777619055729,"stockEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":0.0098},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0802},{"period":"1year","weight":0.0448},{"period":"ytd","weight":-0.0677}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38547人(较上一季度增加1.88%)","perCapita":"25121股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片(制剂)、盐酸昂丹司琼(原料药、制剂)、盐酸格拉司琼(原料药、制剂)、多索茶碱(原料药、制剂)、尼麦角林胶囊、舒林酸片、谷胱甘肽、注射用甲泼尼龙琥珀酸钠、注射用氢化可的松琥珀酸钠、盐酸乐卡地平。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}